#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15614	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2158	715.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1398	1398	C	875	C,T	854,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15614	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2158	715.4	0	HET	.	.	.	C207T	.	207	207	C	421	421	C	885	C,T	672,175	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28946	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	809.8	0	.	n	.	0	T695C	SNP	695	695	T	1045	1045	C	876	C	858	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28946	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	809.8	0	.	n	.	0	A1638G	SNP	1638	1638	A	1988	1988	G	927	G,A	883,24	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28946	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	809.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2321	2321	C	913	C	889	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28946	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	809.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2395	2395	A	892	A	877	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28946	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3552	809.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	2947	2947	C	929	C,T	887,17	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	2040	folP	855	855	100.0	folP.l15.c17.ctg.1	1436	140.5	1	SNP	p	R229S	1	.	.	685	687	AGC	986	988	AGC	203;203;203	A;G;C	199;196;197	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5818	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3497	165.5	1	SNP	p	S91F	1	.	.	271	273	TTC	634	636	TTC	189;187;189	T;T,C;C	187;178,6;185	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5818	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3497	165.5	1	SNP	p	G95N	0	.	.	283	285	GGC	646	648	GGC	195;193;192	G;G,A;C	189;182,6;182	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5818	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3497	165.5	1	SNP	p	D95G	1	.	.	283	285	GGC	646	648	GGC	195;193;192	G;G,A;C	189;182,6;182	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	1774	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1481	118.9	1	SNP	p	G45D	0	.	.	133	135	GGC	569	571	GGC	215;212;214	G;G,A;C	210;207,1;209	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	898	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1044	85.1	0	.	n	.	0	A197.	DEL	197	197	A	603	603	A	196	A	186	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	D86N	0	.	.	256	258	GAC	588	590	GAC	201;202;203	G;A;C	199;194;199	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	R87W	0	.	.	259	261	CGT	591	593	CGT	205;206;207	C,A;G;T	197,5;204;200	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	R87I	0	.	.	259	261	CGT	591	593	CGT	205;206;207	C,A;G;T	197,5;204;200	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	S87R	1	.	.	259	261	CGT	591	593	CGT	205;206;207	C,A;G;T	197,5;204;200	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5408	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2917	183.8	1	SNP	p	S88P	0	.	.	262	264	TCC	594	596	TCC	208;211;212	T;C;C	206;204;210	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4154	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2626	157.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1591	1593	GGC	194;187;184	G;G;C	190;186;182	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	A311V	0	.	.	931	933	GCC	1258	1260	GCC	217;217;219	G;C;C,A	214;215;217,1	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	I312M	1	.	.	934	936	ATG	1261	1263	ATG	225;226;225	A;T;G,C	223;225;220,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	T316P	0	.	.	946	948	ACC	1273	1275	ACC	220;220;215	A,G;C,T;C,A,G	216,1;215,1;209,1,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	V316T	1	.	.	946	948	ACC	1273	1275	ACC	220;220;215	A,G;C,T;C,A,G	216,1;215,1;209,1,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1774	1776	ACC	197;197;200	A;C;C	191;193;198	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1828	1830	GCG	216;218;221	G;C;G	213;213;216	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1828	1830	GCG	216;218;221	G;C;G	213;213;216	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1951	1953	GGT	154;154;152	G,T;G;T,C	146,1;147;140,4	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1960	1962	AGC	151;152;152	A,G;G;C	140,4;147;147	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4138	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2412	169.3	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1978	1980	CCG	125;123;119	C,G;C,G;G	117,1;113,1;109	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5892	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3172	184.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1705	1707	CCG	210;210;210	C;C,T;G	190;198,5;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2770	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1649	164.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	509	509	C	192	C	180	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3130	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1653	187.4	0	.	p	.	0	S175L	NONSYN	523	525	TCA	830	832	TTA	225;225;224	T;T,C;A	218;221,2;221	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3130	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1653	187.4	1	SNP	p	G120K	1	.	.	358	360	AAG	665	667	AAG	253;254;254	A,G,C;A,G;G,T	236,3,1;243,3;231,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3130	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1653	187.4	1	SNP	p	A121N	1	.	.	361	363	AAC	668	670	AAC	254;254;255	A,G;A,C;C	239,3;239,3;235	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3130	porB1b	1038	1038	99.9	porB1b.l15.c4.ctg.1	1653	187.4	1	SNP	p	N121D	0	.	.	361	363	AAC	668	670	AAC	254;254;255	A,G;A,C;C	239,3;239,3;235	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10688	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4911	216.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1176	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1141	102.1	1	SNP	p	V57M	1	.	.	169	171	ATG	637	639	ATG	232;234;231	A;T;G	225;227;226	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
